Indications for implantable cardiac defibrillators in patients with congestive heart failure: Implications of the sudden cardiac death in heart failure trial

Zheng ZJ, Croft JB, Giles WH, Mensah GA: Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104:2158–2163. Hallstrom AP, Ornato JP, Weisfeldt M, et al.: Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004, 351:637–646. Zipes DP, Roberts D: Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995, 92:59–65. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1621–1623. Connolly SJ, Gent M, Roberts RS, et al.: Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000, 101:1297–1302. Kuck KH, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102:748–754. Salukhe TV, Dimopoulos K, Sutton R, et al.: Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation 2004, 109:1848–1853. Bokhari F, Newman D, Greene M, et al.: Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004, 110:112–116. Oseroff O, Retyk E, Bochoeyer A: Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Curr Opin Cardiol 2004, 19:26–30. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: summary article. Circulation 2002, 106:2145. Bigger JT Jr, Fleiss JL, Kleiger R, et al.: The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984, 69:250–258. Singh SN, Fletcher RD, Fisher SG, et al.: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995, 333:121–122. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ: Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990, 82:633–635. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933–1940. Patients with a history of prior MI, LVEF < 0.35, an episode of NSVT, and inducible nonsuppressible VT on EPS were randomized to ICD implantation versus conventional medical therapy. After a mean follow-up of 27 months, there was a 54% relative risk reduction in death from any cause in the ICD group vs the medical therapy group (16% vs 39%). Buxton AE, Lee KL, Fisher JD, et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1996, 335:1933–1940. Moss AJ, Zareba W, Hall WJ, Klein H, et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877–883. Patients with a history of ischemic cardiomyopathy and an LVEF < 0.30 were randomized to ICD implantation versus conventional medical therapy with a primary endpoint of all-cause mortality. During an average follow-up of 20 months, the ICD group exhibited a relative risk reduction of 31% in all-cause mortality. Klein H, Auricchio A, Reek S, Geller C: New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999, 83:91D-97D. Burdy GH: SCD-HEFT results. Presented at the American College of Cardiology. New Orleans, LA. March 2004. http://www.sicr.org/scdheft_results_acc_lbcc.pdf Kadish A, Dyer A, Daubert JP, et al.: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350:2151–2158. Bristow M, Saxon L, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator advanced chronic heart failure. N Engl J Med 2004, 350:2140–2150. The utility of cardiac resynchronization was examined in patients with NYHA functional class III-IV heart failure and with QRS duration over 120 msec and LVEF < 0.35. The COMPANION trial demonstrated a 20% reduction in all-cause hospitalizations and a 36% reduction in mortality alone with theCRT-D device (ICD with biventicular pacing), compared with optimal medical therapy. De-Vreede-Swangemakes J, Gorgels A, Dubois-arbouw W, et al.: Out of hospital cardiac arrest in the 1990’s: a populationbased study of Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997, 30:1500–1505. Wilber DJ, Zareba W, Hall WJ, et al.: Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004, 109:1082–1084. The DAVID Trial Investigators: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115–3123. Hyder M, Davoudi R, Healy E, et al.: Delivery of therapy in association to QRS width in prophylactic ICD implantation. Presented at the 77th Scientific Session of the American Heart Association. New Orleans, LA. November 2004.